BALVERSA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Janssen Products Lp. The primary component is Erdafitinib.
| Product ID | 59676-030_11688298-6399-11ea-8a95-3feefb2ca371 |
| NDC | 59676-030 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BALVERSA |
| Generic Name | Erdafitinib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-04-12 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212018 |
| Labeler Name | Janssen Products LP |
| Substance Name | ERDAFITINIB |
| Active Ingredient Strength | 3 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2019-04-12 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA212018 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-04-12 |
| Marketing Category | NDA |
| Application Number | NDA212018 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-04-12 |
| Ingredient | Strength |
|---|---|
| ERDAFITINIB | 3 mg/1 |
| SPL SET ID: | 2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59676-030 | BALVERSA | Erdafitinib |
| 59676-040 | BALVERSA | Erdafitinib |
| 59676-050 | BALVERSA | Erdafitinib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BALVERSA 87362785 5794954 Live/Registered |
Johnson & Johnson 2017-03-08 |